Genmab U.S., Inc.

NJ · United States · Reporting entity ID 100000956830

Total reported 2019–2025

$54.6M

#162 of 2,960 reporting companies — 0.1% of all reported industry payments

$4.82M in general payments across 21,571 records, plus $49.3M in research funding across 3,617 records.

How it breaks down

General payments $4,816,660

Research funding $49,257,336

Ownership & investment $486,019

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.